Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug;92(2):e12911.
doi: 10.1111/sji.12911. Epub 2020 Jun 17.

Roles of immune responses in the pathogenesis of immunorelated pancytopenia

Na Xiao  1 , Shanfeng Hao  1 , Yang Zhang  1 , Zonghong Shao  1
Affiliations
Free article
Review

Roles of immune responses in the pathogenesis of immunorelated pancytopenia

Na Xiao et al. Scand J Immunol. 2020 Aug.
Free article

Abstract

Some patients with pancytopenia do not conform to any diagnostic criteria of known haematological or non-haematological diseases; however, they respond well to corticosteroid, high-dose intravenous immunoglobulin and rituximab treatment. This abnormality is termed immunorelated pancytopenia (IRP). Later studies indicated that IRP might be a kind of autoimmune disease in which T helper (Th) type 2 cell function is enhanced, resulting in the hyperfunction of B lymphocytes, which then produce excess autoantibodies that attack the bone marrow (BM) and cause cytopenia. Hypofunction of regulatory T (Treg) cells and enhanced Th17 cell function, an elevated percentage of plasmacytoid dendritic cells (pDCs) and a decreased percentage of natural killer (NK) cells help to promote the process. Moreover, increased expression of a synergistic stimulator of B lymphocytes, CD70 and the reactive overexpression of the BCR inhibitory coreceptor CD22 also support this claim. Candidate autoantigens targeted by autoantibodies on haematopoietic cell membranes have also been reported in IRP. This review is focused on studies that demonstrate the role of immune responses in the pathogenesis of IRP. Current diagnostic criteria and treatments for IRP are also referenced to provide a thorough understanding. Distinguishing IRP from idiopathic cytopenias of undetermined significance (ICUS) and other haematological disorders, for example myelodysplastic syndrome (MDS), aplastic anaemia (AA), paroxysmal nocturnal hemoglobinuria (PNH) and Evans syndrome, may help patients with pancytopenia benefit from proper treatment. Further studies are required to achieve new insight into the pathophysiology of IRP with regard to the immune system, which will be instrumental for the development of novel therapies for inhibiting disease initiation and/or progression.

Keywords: autoantibody; immune response; pancytopenia; pathogenesis; treatment.

PubMed Disclaimer

References

REFERENCES

    1. He H, Shao Z, Liu H, et al. Immunorelated pancytopenia. Chin J Hematol. 2001;22:79-82.
    1. He H, Shao Z, Cao Z, et al. Category of bone marrow mononuclear cells Coombs test. Chin J Hematol. 2000;21:550-551.
    1. He H, Shao Z. Research progress on modified direct antiglobulin test. Chin J Lab Med. 2001;24:56-58.
    1. Li Y, Wang X, Fu L, Mu B, Nie Y. The clinical meaning of the bone marrow mononuclear cell antihuman globulin blood grouping to diagnose the immunorelated pancytopenia (IRP). Zhongguo Shi Yan Zhen Duan Xue Za Zhi. 2009;13:1546-1548.
    1. Bing L, Fu R, Liu H, et al. Application of bone marrow indirect Coombs test and its clinical significance in diagnosis of immuno-related pancytopenia. J Exp Hematol. 2012;20:505-509.

LinkOut - more resources